Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2019 Apr 10:6:2333392819841223.
doi: 10.1177/2333392819841223. eCollection 2019 Jan-Dec.

End-of-Life Health-Care Cost of Patients With Lung Cancer: A Retrospective Study

Kyriakos Souliotis  1   2 , Chara Kani  1 , Androniki Marioli  3 , Aggeliki Kamboukou  4 , Aikaterini Prinou  4 , Konstantinos Syrigos  3 , Sophia Markantonis  4
Affiliations

End-of-Life Health-Care Cost of Patients With Lung Cancer: A Retrospective Study

Kyriakos Souliotis et al. Health Serv Res Manag Epidemiol. .

Abstract

Introduction: Lung cancer exerts a significant societal and health-care-related economic burden and chemotherapy drugs constitute a major factor of total direct cost. The aim of the present study was to assess the direct health-care cost of lung cancer in Greece by conducting a retrospective analysis on the last 6 months of life.

Methods: The present study was based on both the medical data and costs of treatment of deceased adult patients who suffered from terminal stage IIIB/IV lung cancer (non-small cell lung cancer and small cell lung cancer) during the last 6 months of their life. The study's protocol was approved by the Hospital's Research Ethics Committee. Costs included outpatient (outpatient services) and inpatient (inpatient services) costs. Descriptive statistics were mainly used for statistical analysis.

Results: The files of 144 patients were analyzed. The total cost of health-care services for the study population during the last 6 months of life was attributed by 57% to inpatient services, whereas chemotherapy costs (74%) comprised the largest proportion of the total inpatient cost. The highest expenditure for outpatient services was attributed to concomitant medication (59%), followed by the cost of tests (21%) and radiotherapy (20%).

Conclusions: The results of our study indicate that both inpatient and outpatient costs were substantial. The main inpatient and outpatient cost drivers were chemotherapy and concomitant medication, respectively. A more comprehensive nationwide study would be useful to validate our results and to include also indirect costs of cancer care in Greece.

Keywords: direct health-care costs; end-stage lung cancer; health services; non-small cell lung cancer; small cell lung cancer.

PubMed Disclaimer

Conflict of interest statement

Declaration of Conflicting Interests: The author(s) declared no potential conflicts of interest with respect to the research, authorship, and/or publication of this article.

Figures

Figure 1.
Figure 1.
The mean cost per patient per month.
Figure 2.
Figure 2.
A, The mean inpatient cost per patient by month and cost category. B, The mean outpatient cost per patient by month and cost category.
See this image and copyright information in PMC

References

    1. European Network of Cancer Registries. ENCR factsheets: Lung Including Trachea and Bronchus (LUNGC) Cancer Factsheet. June 2014. http://www.encr.eu/images/docs/factsheets/ENCR_Factsheet_Lung_2014.pdf. Accessed February 24, 2015.
    1. Ferlay J, Steliarova-Foucher E, Lortet-Tieulent J, et al. Cancer incidence and mortality patterns in Europe: estimates for 40 countries in 2012. Eur J Cancer. 2013;49(6):1374–1403. - PubMed
    1. Luengo-Fernandez R, Leal J, Gray A, Sullivan R. Economic burden of cancer across the European Union: a population-based cost analysis. Lancet Oncol. 2013;14(12):1165–1174. - PubMed
    1. Hanly P, Soerjomataram I, Sharp L. Measuring the societal burden of cancer: the cost of lost productivity due to premature cancer-related mortality in Europe. Int J Cancer. 2014;136(4):136–145. - PubMed
    1. Bosanquet N, Sikora K. The economics of cancer care in the UK. Lancet Oncol. 2004;5(9):568–574. - PubMed

LinkOut - more resources